Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

60.02 -2.73 (-4.36%)
Streaming Delayed Price Updated: 11:46 AM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
45 46 Next >
Prediction: This Will Be Amazon's Next Big Acquisition
Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm over the last several years. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Will The Falling Hims & Hers Stock Price Recover In 2025?
Hims & Hers share price has crashed by over 20% this year after an unfavorable FDA ruling. 
Via Talk Markets
Topics Stocks / Equities
Hims & Hers Stock: Growth, Noise, and Where to Focus Now
Hims & Hers stock is full of noise, but what's the signal for investors? 
Via The Motley Fool
Hims & Hers Health Are Falling Today: What's Going On?
Hims & Hers Health, Inc. (NYSE: HIMS) are trading lower Thursday. The U.S. Food and Drug Administration (FDA) issued a new decision regarding the status of tirzepatide injection shortages, which have... 
Via Benzinga
Is NYSE:HIMS suited for growth investing?
HIMS & HERS HEALTH INC (NYSE:HIMS) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment
 
Via Benzinga
Hims & Hers Health Unusual Options Activity
 
Via Benzinga
From Powell To Profits: Strategic Stock Picks Amid Market Uncertainty
Yesterday's market movement aligned perfectly with expectations, as the FOMC meeting drove significant volatility. 
Via Talk Markets
Topics Stocks / Equities
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
Compounders now have until late March to wind down their operations, depending on their licensing. 
Via Investor's Business Daily
This Is Huge News for Eli Lilly Investors
Eli Lilly just gave investors several reasons to cheer. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Be Careful In This Unforgiving Market. The Tide Is Turning.
Via Talk Markets
Topics Stocks / Equities
Where Hims & Hers Health Stands With Analysts
 
Via Benzinga
Exploring growth characteristics of HIMS & HERS HEALTH INC (NYSE:HIMS).
Should you consider HIMS & HERS HEALTH INC (NYSE:HIMS) for growth investing? 
Via Chartmill
Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity
 
Via Benzinga
Josh Brown Unveils The 'Degen Dow,' A Basket Of 30 Retail Darlings Spanning All 'Major Degen Food Groups'
Ritholtz Wealth Management’s Josh Brown created a new index that tracks the most popular stocks in some of the hottest themes of the market. 
Via Benzinga
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
From Hims & Hers
Via Business Wire
4 Stocks That Crushed Analyst Estimates by More Than Double
Hims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential. 
Via MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Amazon’s Healthcare Gamble: A New Era of Medical Disruption
Amazon's strategic healthcare expansion leverages technology and logistics for a potentially transformative impact on patient care and market dynamics. 
Via MarketBeat
Topics Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick
Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate. 
Via MarketBeat
Topics Government Lawsuit
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in obesity. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
From Hims & Hers
Via Business Wire
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
8 mid-cap stocks saw impressive gains last week. Archer, Scholar Rock, Arrowhead, Iris Energy, Hims & Hers, SoundHound, Joby Aviation, and Urban Outfitters all performed well. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines. 
Via MarketBeat
Topics Government
Why Hims & Hers Stock Jumped on Massive FDA News
Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model. 
Via The Motley Fool
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.